James Peyer, Director, 10% Owner at Sensei Biotherapeutics, Inc. (SNSE), bought 19,949 shares at $3.97 ($80K) on 2022-02-18, disclosed to the SEC on 2022-02-22.
Open-market purchase of $80k SNSE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.17 | 4,949 | $21K | 25.7% |
| 2 | $3.97 | 15,000 | $60K | 74.3% |
| Total | $4.02 avg | 19,949 | $80K | 100% |
| Filing → |
| SNSE | SELL | 2025-12-08 | $398K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $15K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $136K | — | Filing → |